Valuation: LifeMD, Inc.

Market Cap 20Cr 18Cr 16Cr 15Cr 29Cr 1.92TCr 29Cr 196.92Cr 76Cr 947.21Cr 76Cr 75Cr 3.3TCr P/E 2026 *
-15.1x
P/E 2027 * 55.6x
Enterprise Value 20Cr 18Cr 16Cr 15Cr 29Cr 1.92TCr 29Cr 196.92Cr 76Cr 947.21Cr 76Cr 75Cr 3.3TCr EV / Sales 2026 *
0.91x
EV / Sales 2027 * 0.78x
Free-Float
85.35%
Yield 2026 *
-
Yield 2027 * -
1 day-1.67%
1 week-4.18%
Current month-3.50%
1 month-3.50%
3 months+11.02%
6 months+20.06%
Current year+21.11%
1 week 3.9
Extreme 3.9
4.6
1 month 3.9
Extreme 3.9
5.23
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
13.62
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 01/08/2025
Director of Finance/CFO 57 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 04/09/2014
Chairman 43 11/06/2019
Date Insider Type Main position Quantity % Market Cap.
11/05Free

Chief Financial Officer

3,37,500 0.7035%
30/03Free

Responsable ventes & marketing

2,00,000 0.4155%
09/12Sell

Executive/Senior Manager

15,000 0.0312%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-4.18%-69.96%+0.73% 20Cr
+0.71%+15.87%-37.38%-9.06% 2.86TCr
+3.03%+16.49%-27.50%+206.00% 1.42TCr
+0.88%+0.22%-20.12%+51.82% 539.54Cr
-15.81%-13.30% - - 300.55Cr
-0.24%+6.17% - - 216.77Cr
+1.47%+7.34%+41.32%-43.13% 186.1Cr
+1.95%+4.23%-24.96% - 130.23Cr
+2.23%+5.47%-32.62%+236.91% 76Cr
-0.31%-6.98%-43.76%-61.49% 73Cr
Average -1.06%+4.16%-26.87%+54.54% 582.44Cr
Weighted average by Cap. -0.93%+11.13%-30.06%+57.93%

Financials

2026 *2027 *
Net sales 22Cr 19Cr 18Cr 17Cr 32Cr 2.1TCr 32Cr 215.27Cr 84Cr 1.04TCr 83Cr 82Cr 3.61TCr 26Cr 23Cr 21Cr 20Cr 37Cr 2.47TCr 38Cr 252.94Cr 98Cr 1.22TCr 98Cr 96Cr 4.24TCr
Net income -1.31Cr -1.15Cr -1.06Cr -98.93L -1.86Cr -124.13Cr -1.9Cr -13Cr -4.93Cr -61Cr -4.93Cr -4.82Cr -213.16Cr 35.74L 31.3L 28.89L 26.96L 50.73L 34Cr 51.67L 3.47Cr 1.34Cr 17Cr 1.34Cr 1.31Cr 58Cr
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Employees
350
Date Price Change Volume
30/26/30 $4.130 -1.67% 13,96,925
29/26/29 $4.200 +1.69% 14,12,801
26/26/26 $4.130 -1.67% 15,60,447
25/26/25 $4.200 -6.67% 8,51,975
24/26/24 $4.500 -1.10% 10,07,465
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.130USD
Average target price
9.875USD
Spread / Average Target
+139.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock